IP Verse

Taiho Pharmaceutical Co., Ltd. V. Eugia Pharma Specialities, Ltd. - 1:22-cv-01611

Explore the details of the Taiho Pharmaceutical Co., Ltd. V. Eugia Pharma Specialities, Ltd. case under case number 1:22-cv-01611 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:22-cv-01611
Filing Date
Dec 20, 2022
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Aurobindo Pharma Ltd. -
Eugia Pharma Specialities, Ltd. -
Taiho Oncology, Inc. -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US10456399B2
-US10960004B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 27, 2023Letter to The Honorable Colm F. Connolly from Steven J. Balick regarding the Parties' Joint Proposed Scheduling Order. (Balick, Steven) (Entered: 02/27/2023)PACER Document
Feb 28, 2023SCHEDULING & CONSOLIDATION ORDER: Civil Action No. 21-838-CFC shall be the lead case and all future filings shall be made in Lead Case No. 21-838-CFC ONLY. Joinder of Parties due by 6/16/2023. Amended Pleadings due by 6/16/2023. Fact Discovery completed by 9/29/2023. Expert Discovery due by 2/29/2024. Signed by Judge Colm F. Connolly on 2/28/2023. Associated Cases: 1:21-cv-00838-CFC, 1:22-cv-01480-CFC, 1:22-cv-01611-CFC, 1:23-cv-00008-CFC(nmf) (Entered: 02/28/2023)PACER Document
Nov 17, 2023CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities, Ltd., Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. Case reassigned to Magistrate Judge Jennifer L. Hall. Signed by Judge Colm F. Connolly on 11/17/2023. (nmf) (Entered: 11/17/2023)PACER Document
Dec 20, 2022No Summons Issued. (srs)PACER Document
Dec 21, 2022Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)PACER Document
Feb 28, 2023Case associated with lead case: Create association to 1:21-cv-00838-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-838-CFC ONLY. (nmf)PACER Document
Jan 5, 2024Case Assigned to Judge Jennifer L Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:19-cv-02309-JLH, 1:19-cv-02321-JLH, 1:19-cv-02342-JLH, 1:19-cv-02368-JLH, 1:21-cv-00838-JLH, 1:22-cv-01480-JLH, 1:22-cv-01611-JLH, 1:23-cv-00008-JLH, 1:23-cv-01193-JLH(rjb)PACER Document
Apr 2, 2024STIPULATION of Dismissal with Prejudice by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd.. (Whitesell, Angela) (Entered: 04/02/2024)PACER Document
Apr 3, 2024SO ORDERED, re (168 in 1:19-cv-02309-JLH, 19 in 1:23-cv-01193-JLH, 19 in 1:22-cv-01611-JLH, 117 in 1:21-cv-00838-JLH) Stipulation and Order of Dismissal between Plaintiffs and Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and AurobindoPharma USA, Inc. Signed by Judge Jennifer L. Hall on 4/3/2024. Associated Cases: 1:19-cv-02309-JLH, 1:21-cv-00838-JLH, 1:22-cv-01611-JLH, 1:23-cv-01193-JLH(ceg) (Entered: 04/03/2024)PACER Document
Apr 4, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,456,399 B2; 10,960,004 B2. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 04/04/2024)PACER Document
Dec 12, 2024NOTICE of Appearance by Ethan Haller Townsend on behalf of All Plaintiffs (Townsend, Ethan) (Entered: 12/12/2024)PACER Document
Dec 12, 2024MOTION for Pro Hac Vice Appearance of Attorney Michael Sitzman, Esq. and Timothy P. Best, Ph.D. - filed by Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc.. (Townsend, Ethan) (Entered: 12/12/2024)PACER Document
Apr 3, 2024CASE CLOSED per D.I. 20 . (ceg)PACER Document
Dec 12, 2024Pro Hac Vice Fee - Credit Card Payment received for Michael Sitzman and Timothy P. Best. ( re 23 MOTION for Pro Hac Vice Appearance of Attorney Michael Sitzman, Esq. and Timothy P. Best, Ph.D. )( Payment of $ 100, receipt number ADEDC-4568911).(Townsend, Ethan) (Entered: 12/12/2024)PACER Document
Dec 17, 2024Remark: The motion at D.I. 23 has been terminated. This case is consolidated with Lead Civil Action 21cv838-JLH. All filings are to be made in the Lead Civil Action only. The Court's Finance Department has confirmed refund of payment. (ceg) (Entered: 12/17/2024)PACER Document